VSL#3 can prevent ulcerative colitis-associated carcinogenesis in mice

Table 4 Comparison of fecal microbiota (abundance)

Genus	Control (%)	Model (%)	5-ASA (%)	VSL#3 (%)	5-ASA + VSL#3 (%)
Lactobacillus	4.77	3.261	2.65	4.06	9.864
Oscillibacter	0.64	1.301	0.542	0.523	0.794
Lachnoclostridium	0.45	1.191	0.482	0.393	1.08
Bacillus	1.01	0.98	24.002	23.343	0.66
Lactococcus	2.30	2.29	8.582	7.863	1.59

¹P < 0.05 between the model and control groups;

²P < 0.05 between the model and 5-ASA groups;

³P < 0.05 between the model and VSL#3 groups;

⁴P < 0.05 between the model and 5-ASA + VSL#3 groups.